[Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].
D000328:Adult; D000368:Aged; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications* / Q000628:therapy
D006887:Hydroxycholecalciferols; C008088:alfacalcidol
Effetti del trattamento con 1-alfa-idrossivitamina D3 nell'osteodistrofia dell'uremico in trattamento emodialitico periodico.